Stay informed with the latest litigation news. Explore now

IP Verse

Boehringer Ingelheim Rcv Boehringer Ingelheim competitive analysis

Latest publications and patents of Boehringer Ingelheim Rcv Boehringer Ingelheim New

Explore the latest publications and patents granted to Boehringer Ingelheim Rcv Boehringer Ingelheim, showcasing their recent innovations and technological advancements.

Latest oppositions filed by Boehringer Ingelheim Rcv Boehringer Ingelheim

Explore patent oppositions filed by Boehringer Ingelheim Rcv Boehringer Ingelheim against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 4, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3342786	Anti-Dll3 Antibody	CHUGAI SEIYAKU KABUSHIKI KAISHA	Mar 22, 2022
EP3177645	Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of Cancer	LINDHOFER	Nov 16, 2021
EP2820151	Cancer Patient Selection For Administration Of Wnt Signaling Inhibitors Using Rnf43 Mutation Status	IRM	Dec 15, 2020
EP2847223	Anti-B7-H6 Antibody, Fusion Proteins, And Methods Of Using The Same	TRUSTEES OF DARTMOUTH COLLEGE	Dec 20, 2019
EP2647707	Cytotoxicity-Inducing Therapeutic Agent	CHUGAI SEIYAKU KABUSHIKI KAISHA	Jun 12, 2019
EP2530091	Anti-Dll3 Antibody	CHUGAI SEIYAKU KABUSHIKI KAISHA	Jan 2, 2019
EP2567709	Molecules And Methods For Modulating Low-Density-Lipoprotein Receptor-Related Protein 6 (Lrp6)	NOVARTIS	Sep 25, 2018

Latest PTAB cases involving Boehringer Ingelheim Rcv Boehringer Ingelheim New

Discover the latest PTAB cases involving Boehringer Ingelheim Rcv Boehringer Ingelheim, highlighting their recent legal challenges and patent disputes.